NASDAQ$ETNB

89Bio Inc · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Reports awaiting report

89Bio hasn't published Q3 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2025

    Revenue
    $0.00
    EPS
    -$0.49
  • Year-ago · Q3 2024

    Q3 2024

    Revenue
    $0.00
    EPS
    -$1.39
  • FY2025 consensus

    Analyst consensus

    Revenue
    $2.92M
    EPS
    -$2.59

Revenue & EPS history

89Bio · Revenue · Quarterly

$0

Q1 2025
Beat estimate in 0 of 2 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 7 quarterly earnings reports

Historical avg

-0.1%

Avg return

Earnings day

-4.6%

Avg return

5 days after

-2.8%

Avg return

30 days after

54%

13 / 24 earnings

Positive

+14.8%

Q4 2019

Best reaction

-19.4%

Q1 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025———
Q2 2025+1.7%+1.3%-1.7%
Q1 2025-3.7%-4.1%+18.6%
Q4 2024-1.0%-7.1%-3.7%
Q3 2024+2.8%-10.9%-20.6%
Q2 2024-10.9%-11.8%-0.9%
Q1 2024-3.5%+0.8%-10.2%
Q4 2023+7.3%-0.2%-1.3%
Q3 2023-11.8%——
Q2 2023+5.3%——
Q1 2023+1.3%——
Q4 2022-1.1%——
Q3 2022+14.2%——
Q2 2022+3.6%——
Q1 2022+14.6%——
Q4 2021+5.1%——
Q3 2021+1.4%——
Q2 2021+1.1%——
Q1 2021-19.4%——
Q4 2020-4.7%——
Q3 2020-0.8%——
Q2 2020+1.6%——
Q1 2020-6.2%——
Q4 2019+14.8%——
Q3 2019-13.5%——
Q2 2019———
Q1 2019———
Q4 2018———
Q3 2018———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro